ID   DUOX2_HUMAN             Reviewed;        1548 AA.
AC   Q9NRD8; A8MQ13; D2XI64; Q9NR02; Q9UHF9;
DT   21-FEB-2006, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   10-MAY-2017, entry version 142.
DE   RecName: Full=Dual oxidase 2;
DE            EC=1.11.1.-;
DE            EC=1.6.3.1;
DE   AltName: Full=Large NOX 2;
DE   AltName: Full=Long NOX 2;
DE   AltName: Full=NADH/NADPH thyroid oxidase p138-tox;
DE   AltName: Full=NADPH oxidase/peroxidase DUOX2;
DE   AltName: Full=NADPH thyroid oxidase 2;
DE   AltName: Full=Thyroid oxidase 2;
DE   AltName: Full=p138 thyroid oxidase;
DE   Flags: Precursor;
GN   Name=DUOX2; Synonyms=LNOX2, THOX2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], INDUCTION, TISSUE SPECIFICITY, AND VARIANT
RP   LEU-1067.
RC   TISSUE=Thyroid;
RX   PubMed=10806195; DOI=10.1074/jbc.M000916200;
RA   De Deken X., Wang D., Many M.-C., Costagliola S., Libert F.,
RA   Vassart G., Dumont J.E., Miot F.;
RT   "Cloning of two human thyroid cDNAs encoding new members of the NADPH
RT   oxidase family.";
RL   J. Biol. Chem. 275:23227-23233(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANTS LEU-138 AND LEU-1067,
RP   DEVELOPMENTAL STAGE, AND TISSUE SPECIFICITY.
RC   TISSUE=Pancreas, and Thyroid;
RX   PubMed=11514595; DOI=10.1083/jcb.200103132;
RA   Edens W.A., Sharling L., Cheng G., Shapira R., Kinkade J.M., Lee T.,
RA   Edens H.A., Tang X., Sullards C., Flaherty D.B., Benian G.M.,
RA   Lambeth J.D.;
RT   "Tyrosine cross-linking of extracellular matrix is catalyzed by Duox,
RT   a multidomain oxidase/peroxidase with homology to the phagocyte
RT   oxidase subunit gp91phox.";
RL   J. Cell Biol. 154:879-891(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 339-1548, AND VARIANT LEU-1067.
RC   TISSUE=Thyroid;
RX   PubMed=10601291; DOI=10.1074/jbc.274.52.37265;
RA   Dupuy C., Ohayon R., Valent A., Noel-Hudson M.-S., Deme D., Virion A.;
RT   "Purification of a novel flavoprotein involved in the thyroid NADPH
RT   oxidase. Cloning of the porcine and human cDNAs.";
RL   J. Biol. Chem. 274:37265-37269(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1509-1548, VARIANT TDH6 SER-1518,
RP   AND CHARACTERIZATION OF VARIANT TDH6 SER-1518.
RX   PubMed=20187165; DOI=10.1002/humu.21227;
RA   Hoste C., Rigutto S., Van Vliet G., Miot F., De Deken X.;
RT   "Compound heterozygosity for a novel hemizygous missense mutation and
RT   a partial deletion affecting the catalytic core of the H2O2-generating
RT   enzyme DUOX2 associated with transient congenital hypothyroidism.";
RL   Hum. Mutat. 31:E1304-E1319(2010).
RN   [6]
RP   GLYCOSYLATION.
RX   PubMed=11822874; DOI=10.1006/excr.2001.5444;
RA   De Deken X., Wang D., Dumont J.E., Miot F.;
RT   "Characterization of ThOX proteins as components of the thyroid
RT   H(2)O(2)-generating system.";
RL   Exp. Cell Res. 273:187-196(2002).
RN   [7]
RP   INVOLVEMENT IN TDH6.
RX   PubMed=12110737; DOI=10.1056/NEJMoa012752;
RA   Moreno J.C., Bikker H., Kempers M.J.E., van Trotsenburg A.S., Baas F.,
RA   de Vijlder J.J.M., Vulsma T., Ris-Stalpers C.;
RT   "Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and
RT   congenital hypothyroidism.";
RL   N. Engl. J. Med. 347:95-102(2002).
RN   [8]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=12824283; DOI=10.1096/fj.02-1104fje;
RA   Geiszt M., Witta J., Baffi J., Lekstrom K., Leto T.L.;
RT   "Dual oxidases represent novel hydrogen peroxide sources supporting
RT   mucosal surface host defense.";
RL   FASEB J. 17:1502-1504(2003).
RN   [9]
RP   TISSUE SPECIFICITY.
RX   PubMed=15210697; DOI=10.1074/jbc.M404983200;
RA   Schwarzer C., Machen T.E., Illek B., Fischer H.;
RT   "NADPH oxidase-dependent acid production in airway epithelial cells.";
RL   J. Biol. Chem. 279:36454-36461(2004).
RN   [10]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=15591162; DOI=10.1152/ajpgi.00198.2004;
RA   Ameziane-El-Hassani R., Benfares N., Caillou B., Talbot M.,
RA   Sabourin J.-C., Belotte V., Morand S., Gnidehou S., Agnandji D.,
RA   Ohayon R., Kaniewski J., Noel-Hudson M.-S., Bidart J.-M.,
RA   Schlumberger M., Virion A., Dupuy C.;
RT   "Dual oxidase2 is expressed all along the digestive tract.";
RL   Am. J. Physiol. 288:G933-G942(2005).
RN   [11]
RP   INTERACTION WITH TXNDC11; TPO AND CYBA.
RX   PubMed=15561711; DOI=10.1074/jbc.M407709200;
RA   Wang D., De Deken X., Milenkovic M., Song Y., Pirson I., Dumont J.E.,
RA   Miot F.;
RT   "Identification of a novel partner of duox: EFP1, a thioredoxin-
RT   related protein.";
RL   J. Biol. Chem. 280:3096-3103(2005).
RN   [12]
RP   CATALYTIC ACTIVITY, AND ENZYME REGULATION.
RX   PubMed=15972824; DOI=10.1074/jbc.M500516200;
RA   Ameziane-El-Hassani R., Morand S., Boucher J.L., Frapart Y.-M.,
RA   Apostolou D., Agnandji D., Gnidehou S., Ohayon R., Noel-Hudson M.-S.,
RA   Francon J., Lalaoui K., Virion A., Dupuy C.;
RT   "Dual oxidase-2 has an intrinsic Ca2+-dependent H2O2-generating
RT   activity.";
RL   J. Biol. Chem. 280:30046-30054(2005).
RN   [13]
RP   VARIANT TDH6 TRP-376.
RX   PubMed=16134168; DOI=10.1002/humu.9372;
RA   Vigone M.C., Fugazzola L., Zamproni I., Passoni A., Di Candia S.,
RA   Chiumello G., Persani L., Weber G.;
RT   "Persistent mild hypothyroidism associated with novel sequence
RT   variants of the DUOX2 gene in two siblings.";
RL   Hum. Mutat. 26:395-395(2005).
RN   [14]
RP   VARIANT TDH6 HIS-36.
RX   PubMed=16322276; DOI=10.1373/clinchem.2005.058321;
RA   Varela V., Rivolta C.M., Esperante S.A., Gruneiro-Papendieck L.,
RA   Chiesa A., Targovnik H.M.;
RT   "Three mutations (p.Q36H, p.G418fsX482, and g.IVS19-2A-->C) in the
RT   dual oxidase 2 gene responsible for congenital goiter and iodide
RT   organification defect.";
RL   Clin. Chem. 52:182-191(2006).
RN   [15]
RP   POSSIBLE INVOLVEMENT IN INFLAMMATORY BOWEL DISEASE, VARIANTS CYS-1211
RP   AND CYS-1492, AND SUBCELLULAR LOCATION.
RX   PubMed=26301257; DOI=10.1016/j.jcmgh.2015.06.005;
RA   Hayes P., Dhillon S., O'Neill K., Thoeni C., Hui K.Y., Elkadri A.,
RA   Guo C.H., Kovacic L., Aviello G., Alvarez L.A., Griffiths A.M.,
RA   Snapper S.B., Brant S.R., Doroshow J.H., Silverberg M.S., Peter I.,
RA   McGovern D.P., Cho J., Brumell J.H., Uhlig H.H., Bourke B.,
RA   Muise A.A., Knaus U.G.;
RT   "Defects in NADPH oxidase genes NOX1 and DUOX2 in very early onset
RT   inflammatory bowel disease.";
RL   Cell. Mol. Gastroenterol. Hepatol. 1:489-502(2015).
CC   -!- FUNCTION: Generates hydrogen peroxide which is required for the
CC       activity of thyroid peroxidase/TPO and lactoperoxidase/LPO. Plays
CC       a role in thyroid hormones synthesis and lactoperoxidase-mediated
CC       antimicrobial defense at the surface of mucosa. May have its own
CC       peroxidase activity through its N-terminal peroxidase-like domain.
CC       {ECO:0000269|PubMed:12824283}.
CC   -!- CATALYTIC ACTIVITY: NAD(P)H + O(2) = NAD(P)(+) + H(2)O(2).
CC       {ECO:0000269|PubMed:15972824}.
CC   -!- ENZYME REGULATION: Peroxidase activity is inhibited by
CC       aminobenzohydrazide (By similarity). The NADPH oxidase activity is
CC       calcium-dependent. {ECO:0000250, ECO:0000269|PubMed:15972824}.
CC   -!- PATHWAY: Hormone biosynthesis; thyroid hormone biosynthesis.
CC   -!- SUBUNIT: Interacts with TXNDC11, TPO and CYBA.
CC       {ECO:0000269|PubMed:15561711}.
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:15591162, ECO:0000269|PubMed:26301257}; Multi-
CC       pass membrane protein {ECO:0000269|PubMed:15591162}. Cell junction
CC       {ECO:0000269|PubMed:26301257}. Note=Localizes to the apical
CC       membrane of epithelial cells. Localizes on internal membrane
CC       structures under resting conditions, translocates to the plasma
CC       membrane and cell-cell junctions upon challenge with enteric
CC       pathogens, such as Escherichia coli.
CC       {ECO:0000269|PubMed:26301257}.
CC   -!- TISSUE SPECIFICITY: Expressed in colon, small intestine, duodenum
CC       and tracheal surface epithelial cells (at protein level).
CC       Expressed in thyrocytes. Also detected in kidney, liver, lung,
CC       pancreas, prostate, salivary glands, rectum and testis.
CC       {ECO:0000269|PubMed:10806195, ECO:0000269|PubMed:11514595,
CC       ECO:0000269|PubMed:12824283, ECO:0000269|PubMed:15210697,
CC       ECO:0000269|PubMed:15591162}.
CC   -!- DEVELOPMENTAL STAGE: Widely expressed in fetal tissues.
CC       {ECO:0000269|PubMed:11514595}.
CC   -!- INDUCTION: By forskolin, thyrotropin and the Th1-specific cytokine
CC       IFNG/IFN-gamma. {ECO:0000269|PubMed:10806195}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:11822874}.
CC   -!- DISEASE: Thyroid dyshormonogenesis 6 (TDH6) [MIM:607200]: A
CC       disorder due to a defective conversion of accumulated iodide to
CC       organically bound iodine. The iodide organification defect can be
CC       partial or complete. {ECO:0000269|PubMed:12110737,
CC       ECO:0000269|PubMed:16134168, ECO:0000269|PubMed:16322276,
CC       ECO:0000269|PubMed:20187165}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=Defects in DUOX2 may play a role in the pathogenesis
CC       of very early onset inflammatory bowel disease (VEOIBD), a
CC       chronic, relapsing inflammation of the gastrointestinal tract with
CC       a complex etiology diagnosed before 6 years of age. VEOIBD is
CC       subdivided into Crohn disease and ulcerative colitis phenotypes.
CC       Crohn disease may affect any part of the gastrointestinal tract
CC       from the mouth to the anus, but the phenotype of children with
CC       onset of Crohn disease occurring younger than the age of 10 is
CC       predominantly colonic, with a lower risk of ileal disease. Bowel
CC       inflammation is transmural and discontinuous; it may contain
CC       granulomas or be associated with intestinal or perianal fistulas.
CC       In contrast, in ulcerative colitis, the inflammation is continuous
CC       and limited to rectal and colonic mucosal layers; fistulas and
CC       granulomas are not observed. Both diseases include extraintestinal
CC       inflammation of the skin, eyes, or joints.
CC       {ECO:0000269|PubMed:26301257}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the peroxidase
CC       family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Undiagnosed Disease Network; Note=DUOX2;
CC       URL="https://undiagnosed.hms.harvard.edu/updates/genes-of-interest/duox2-gene/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF230496; AAF73922.1; -; mRNA.
DR   EMBL; AF267981; AAF78954.1; -; mRNA.
DR   EMBL; AC091117; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF181972; AAF20055.1; -; mRNA.
DR   EMBL; GU174495; ADB22378.1; -; Genomic_DNA.
DR   CCDS; CCDS10117.1; -.
DR   RefSeq; NP_054799.4; NM_014080.4.
DR   UniGene; Hs.71377; -.
DR   ProteinModelPortal; Q9NRD8; -.
DR   IntAct; Q9NRD8; 1.
DR   STRING; 9606.ENSP00000373691; -.
DR   PeroxiBase; 3338; HsDuOx02.
DR   TCDB; 5.B.1.1.7; the phagocyte (gp91(phox)) nadph oxidase family.
DR   iPTMnet; Q9NRD8; -.
DR   PhosphoSitePlus; Q9NRD8; -.
DR   BioMuta; DUOX2; -.
DR   DMDM; 296434485; -.
DR   PaxDb; Q9NRD8; -.
DR   PeptideAtlas; Q9NRD8; -.
DR   PRIDE; Q9NRD8; -.
DR   DNASU; 50506; -.
DR   Ensembl; ENST00000603300; ENSP00000475084; ENSG00000140279.
DR   GeneID; 50506; -.
DR   KEGG; hsa:50506; -.
DR   UCSC; uc010bea.4; human.
DR   CTD; 50506; -.
DR   DisGeNET; 50506; -.
DR   GeneCards; DUOX2; -.
DR   H-InvDB; HIX0038086; -.
DR   HGNC; HGNC:13273; DUOX2.
DR   MalaCards; DUOX2; -.
DR   MIM; 606759; gene.
DR   MIM; 607200; phenotype.
DR   neXtProt; NX_Q9NRD8; -.
DR   OpenTargets; ENSG00000140279; -.
DR   Orphanet; 95716; Familial thyroid dyshormonogenesis.
DR   Orphanet; 226316; Genetic transient congenital hypothyroidism.
DR   PharmGKB; PA27517; -.
DR   eggNOG; KOG0039; Eukaryota.
DR   eggNOG; ENOG410XNZY; LUCA.
DR   GeneTree; ENSGT00550000074350; -.
DR   HOGENOM; HOG000231774; -.
DR   HOVERGEN; HBG080428; -.
DR   InParanoid; Q9NRD8; -.
DR   KO; K13411; -.
DR   OrthoDB; EOG091G00PO; -.
DR   PhylomeDB; Q9NRD8; -.
DR   TreeFam; TF105424; -.
DR   BRENDA; 1.6.3.1; 2681.
DR   Reactome; R-HSA-209968; Thyroxine biosynthesis.
DR   SABIO-RK; Q9NRD8; -.
DR   UniPathway; UPA00194; -.
DR   ChiTaRS; DUOX2; human.
DR   GeneWiki; Dual_oxidase_2; -.
DR   GenomeRNAi; 50506; -.
DR   PRO; PR:Q9NRD8; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000140279; -.
DR   CleanEx; HS_DUOX2; -.
DR   ExpressionAtlas; Q9NRD8; baseline and differential.
DR   Genevisible; Q9NRD8; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0016174; F:NAD(P)H oxidase activity; IDA:UniProtKB.
DR   GO; GO:0004601; F:peroxidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0048855; P:adenohypophysis morphogenesis; IEA:Ensembl.
DR   GO; GO:0030282; P:bone mineralization; IEA:Ensembl.
DR   GO; GO:0042335; P:cuticle development; ISS:UniProtKB.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IDA:UniProtKB.
DR   GO; GO:0009566; P:fertilization; IEA:Ensembl.
DR   GO; GO:0042446; P:hormone biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0042744; P:hydrogen peroxide catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0048839; P:inner ear development; IEA:Ensembl.
DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0055114; P:oxidation-reduction process; TAS:UniProtKB.
DR   GO; GO:0051591; P:response to cAMP; IDA:UniProtKB.
DR   GO; GO:0006979; P:response to oxidative stress; IEA:InterPro.
DR   GO; GO:0009615; P:response to virus; IDA:UniProtKB.
DR   GO; GO:0030878; P:thyroid gland development; IEA:Ensembl.
DR   GO; GO:0006590; P:thyroid hormone generation; TAS:Reactome.
DR   CDD; cd00051; EFh; 2.
DR   Gene3D; 1.10.640.10; -; 1.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR013112; FAD-bd_8.
DR   InterPro; IPR017927; Fd_Rdtase_FAD-bd.
DR   InterPro; IPR013130; Fe3_Rdtase_TM_dom.
DR   InterPro; IPR013121; Fe_red_NAD-bd_6.
DR   InterPro; IPR010255; Haem_peroxidase.
DR   InterPro; IPR019791; Haem_peroxidase_animal.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   Pfam; PF03098; An_peroxidase; 1.
DR   Pfam; PF00036; EF-hand_1; 1.
DR   Pfam; PF08022; FAD_binding_8; 1.
DR   Pfam; PF01794; Ferric_reduct; 1.
DR   Pfam; PF08030; NAD_binding_6; 1.
DR   PRINTS; PR00457; ANPEROXIDASE.
DR   SMART; SM00054; EFh; 2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF48113; SSF48113; 1.
DR   SUPFAM; SSF63380; SSF63380; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 3.
DR   PROSITE; PS51384; FAD_FR; 1.
DR   PROSITE; PS50292; PEROXIDASE_3; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell junction; Cell membrane; Complete proteome;
KW   Congenital hypothyroidism; Disease mutation; FAD; Flavoprotein;
KW   Glycoprotein; Hydrogen peroxide; Membrane; Metal-binding; NADP;
KW   Oxidoreductase; Peroxidase; Polymorphism; Reference proteome; Repeat;
KW   Signal; Thyroid hormones biosynthesis; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     25       {ECO:0000255}.
FT   CHAIN        26   1548       Dual oxidase 2.
FT                                /FTId=PRO_0000223349.
FT   TOPO_DOM     26    601       Extracellular. {ECO:0000255}.
FT   TRANSMEM    602    622       Helical. {ECO:0000255}.
FT   TOPO_DOM    623   1041       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1042   1062       Helical. {ECO:0000255}.
FT   TOPO_DOM   1063   1076       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1077   1097       Helical. {ECO:0000255}.
FT   TOPO_DOM   1098   1148       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1149   1169       Helical. {ECO:0000255}.
FT   TOPO_DOM   1170   1185       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1186   1206       Helical. {ECO:0000255}.
FT   TOPO_DOM   1207   1223       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM   1224   1244       Helical. {ECO:0000255}.
FT   TRANSMEM   1245   1265       Helical. {ECO:0000255}.
FT   TOPO_DOM   1266   1548       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      819    854       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      855    890       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      899    934       EF-hand 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN     1084   1266       Ferric oxidoreductase.
FT   DOMAIN     1267   1373       FAD-binding FR-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00716}.
FT   CA_BIND     832    843       1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     868    879       2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   REGION       30    596       Peroxidase-like; mediates peroxidase
FT                                activity. {ECO:0000250}.
FT   REGION      960   1245       Interaction with TXNDC11. {ECO:0000250}.
FT   CARBOHYD    100    100       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    348    348       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    382    382       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    455    455       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    537    537       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT      36     36       Q -> H (in TDH6).
FT                                {ECO:0000269|PubMed:16322276}.
FT                                /FTId=VAR_025323.
FT   VARIANT     138    138       P -> L (in dbSNP:rs2001616).
FT                                {ECO:0000269|PubMed:11514595}.
FT                                /FTId=VAR_025324.
FT   VARIANT     376    376       R -> W (in TDH6; dbSNP:rs119472029).
FT                                {ECO:0000269|PubMed:16134168}.
FT                                /FTId=VAR_025325.
FT   VARIANT     678    678       H -> R (in dbSNP:rs57659670).
FT                                /FTId=VAR_061177.
FT   VARIANT    1067   1067       S -> L (in dbSNP:rs269868).
FT                                {ECO:0000269|PubMed:10601291,
FT                                ECO:0000269|PubMed:10806195,
FT                                ECO:0000269|PubMed:11514595}.
FT                                /FTId=VAR_047075.
FT   VARIANT    1211   1211       R -> C (found in a patient with very
FT                                early onset inflammatory bowel disease;
FT                                unknown pathological significance; no
FT                                effect on subcellular location;
FT                                significantly reduced ROS generation,
FT                                which may decrease resistance to
FT                                infection by enteric pathogens, such as
FT                                Escherichia coli; dbSNP:rs747720952).
FT                                {ECO:0000269|PubMed:26301257}.
FT                                /FTId=VAR_075549.
FT   VARIANT    1492   1492       R -> C (found in a patient with very
FT                                early onset inflammatory bowel disease;
FT                                unknown pathological significance; no
FT                                effect on subcellular location;
FT                                significantly reduced ROS generation,
FT                                which may decrease resistance to
FT                                infection by enteric pathogens, such as
FT                                Escherichia coli; dbSNP:rs374410986).
FT                                {ECO:0000269|PubMed:26301257}.
FT                                /FTId=VAR_075550.
FT   VARIANT    1518   1518       G -> S (in TDH6; the enzyme is non-
FT                                functional; expressed at the cell surface
FT                                of cells albeit at low level;
FT                                dbSNP:rs368512412).
FT                                {ECO:0000269|PubMed:20187165}.
FT                                /FTId=VAR_064619.
FT   CONFLICT     25     25       N -> S (in Ref. 1; AAF73922 and 2;
FT                                AAF78954). {ECO:0000305}.
FT   CONFLICT    984    984       A -> V (in Ref. 2; AAF78954).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1548 AA;  175364 MW;  7BAA2350EC0A2A7E CRC64;
     MLRARPEALM LLGALLTGSL GPSGNQDALS LPWEVQRYDG WFNNLRHHER GAVGCRLQRR
     VPANYADGVY QALEEPQLPN PRRLSNAATR GIAGLPSLHN RTVLGVFFGY HVLSDVVSVE
     TPGCPAEFLN IRIPPGDPVF DPDQRGDVVL PFQRSRWDPE TGRSPSNPRD LANQVTGWLD
     GSAIYGSSHS WSDALRSFSG GQLASGPDPA FPRDSQNPLL MWAAPDPATG QNGPRGLYAF
     GAERGNREPF LQALGLLWFR YHNLWAQRLA RQHPDWEDEE LFQHARKRVI ATYQNIAVYE
     WLPSFLQKTL PEYTGYRPFL DPSISPEFVV ASEQFFSTMV PPGVYMRNAS CHFRKVLNKG
     FQSSQALRVC NNYWIRENPN LNSTQEVNEL LLGMASQISE LEDNIVVEDL RDYWPGPGKF
     SRTDYVASSI QRGRDMGLPS YSQALLAFGL DIPRNWSDLN PNVDPQVLEA TAALYNQDLS
     QLELLLGGLL ESHGDPGPLF SAIVLDQFVR LRDGDRYWFE NTRNGLFSKK EIEDIRNTTL
     RDVLVAVINI DPSALQPNVF VWHKGAPCPQ PKQLTTDGLP QCAPLTVLDF FEGSSPGFAI
     TIIALCCLPL VSLLLSGVVA YFRGREHKKL QKKLKESVKK EAAKDGVPAM EWPGPKERSS
     PIIIQLLSDR CLQVLNRHLT VLRVVQLQPL QQVNLILSNN RGCRTLLLKI PKEYDLVLLF
     SSEEERGAFV QQLWDFCVRW ALGLHVAEMS EKELFRKAVT KQQRERILEI FFRHLFAQVL
     DINQADAGTL PLDSSQKVRE ALTCELSRAE FAESLGLKPQ DMFVESMFSL ADKDGNGYLS
     FREFLDILVV FMKGSPEDKS RLMFTMYDLD ENGFLSKDEF FTMMRSFIEI SNNCLSKAQL
     AEVVESMFRE SGFQDKEELT WEDFHFMLRD HDSELRFTQL CVKGGGGGGN GIRDIFKQNI
     SCRVSFITRT PGERSHPQGL GPPAPEAPEL GGPGLKKRFG KKAAVPTPRL YTEALQEKMQ
     RGFLAQKLQQ YKRFVENYRR HIVCVAIFSA ICVGVFADRA YYYGFASPPS DIAQTTLVGI
     ILSRGTAASV SFMFSYILLT MCRNLITFLR ETFLNRYVPF DAAVDFHRWI AMAAVVLAIL
     HSAGHAVNVY IFSVSPLSLL ACIFPNVFVN DGSKLPQKFY WWFFQTVPGM TGVLLLLVLA
     IMYVFASHHF RRRSFRGFWL THHLYILLYA LLIIHGSYAL IQLPTFHIYF LVPAIIYGGD
     KLVSLSRKKV EISVVKAELL PSGVTYLQFQ RPQGFEYKSG QWVRIACLAL GTTEYHPFTL
     TSAPHEDTLS LHIRAVGPWT TRLREIYSSP KGNGCAGYPK LYLDGPFGEG HQEWHKFEVS
     VLVGGGIGVT PFASILKDLV FKSSLGSQML CKKIYFIWVT RTQRQFEWLA DIIQEVEEND
     HQDLVSVHIY VTQLAEKFDL RTTMLYICER HFQKVLNRSL FTGLRSITHF GRPPFEPFFN
     SLQEVHPQVR KIGVFSCGPP GMTKNVEKAC QLVNRQDRAH FMHHYENF
//
